Abstract
Hormone replacement therapy (HRT) protocols for older transgender and gender nonconforming (TGNC) people are based on existing standards of care for TGNC adults and clear frameworks for how to conduct patient assessments for initiation of HRT. However, biomedical interventions and practice recommendations for gender-affirming HRT for older TGNC adults are not comprehensively or explicitly described. Practice recommendations herein examine assessment, risk, benefit, and treatment for older TGNC adults including utilization of shared clinical decision-making with patients and use of informed consent models. Also recommended is utilization of a biopsychosocial approach that examines the impact of life course events, experiences, and HRT intervention on the dimensions of successful aging. Medical management of HRT is well within the scope of primary care and often is a minor addition to the TGNC individual’s clinical care. Few long-term health conditions pose an absolute contraindication to initiation of HRT, and hormone treatment modalities are well-tolerated by older TGNC adults when combined with medical management of multiple chronic conditions of aging.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adkins BD, Barlow AB, Coogan AC, Desouki MM, Jack A, Schultenover SJ, Weiss VL. Characteristic findings of cervical Papanicolaou tests from transgender patients on androgen therapy: challenges in detecting dysplasia. Cytopathology. 2018;29:281. https://doi.org/10.1111/cyt.12525.
American Geriatrics Society. Updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227–46. https://doi.org/10.1111/jgs.13702.
Arnold JD, Sarkodie EP, Coleman ME, Goldstein DA. Incidence of venous thromboembolism in transgender women receiving oral estradiol. J Sex Med. 2016;4(5):1241–6.
Babb SD, Gentzke AS, Jamal A, Phillips E, Homa DM, King BA, Neff LJ. Current cigarette smoking among adults — United States, 2016. Morb Mortal Wkly Rep. 2018;67:53–9. https://doi.org/10.15585/mmwr.mm6702a1.
Baker KE. The future of transgender coverage. N Engl J Med. 2017;376(19):1801–4.
Bergendal A, Kieler H, Sundström A, Lindén Hirschberg A, Kocoska-Maras L. Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration. Menopause. 2016;1:593. https://doi.org/10.1097/GME.0000000000000611.
Bjerrum L, Andersen M, Petersen G, Kragstrup J. Exposure to potential drug interactions in primary health care. Scand J Prim Health Care. 2003;21(3):153–8.
Bidwell, et al. Factors associated with gender-affirming surgery and age of hormone therapy initiation among transgender adults. Transgend Health. 2017;2(1):156–64. https://doi.org/10.1089/trgh.2017.0028.
Buchting FO, Emory KT, Scout, Kim Y, Fagan P, Vera LE, Emery S. Transgender use of cigarettes, cigars, and E-cigarettes in a national study. Am J Prev Med. 2017;53(1):e1–7. https://doi.org/10.1016/j.amepre.2016.11.022. Epub 2017 Jan 13
Canonico M, Plu-Bureau G, Lowe GD, Scarabin PY. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ. 2008;336(7655):1227–31.
Centers for Disease Control and Prevention. Diagnoses of HIV infection among adults aged 50 years and older in the United States and dependent areas, 2010–2014. HIV Surveillance Supplemental Report 2016;21(2) http://wwwcdcgov/hiv/library/reports/surveillance/. Published May 2016. Accessed May 21, 2018.
Coleman E, Bockting W, Botzer M, Cohen-Kettenis P, DeCuypere G, Feldman J, et al. Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int J Transgend. 2012;13(4):165–232.
Deutsch MB. Use of the informed consent model in the provision of cross-sex hormone therapy: a survey of the practices of selected clinics. Int J Transgend. 2012;13(3):140–6.
Deutsch MB. Guidelines for the primary and gender-affirming care of transgender and gender nonbinary people. 2nd ed. San Francisco: Center of Excellence for Transgender Health, Department of Family and Community Medicine, University of California; 2016. Available at: www.transhealth.ucsf.edu/.
Ettner R. Care of the elderly transgender patient. Curr Opin Endocrinol Diabetes Obes. 2013;20(6):580–4. https://doi.org/10.1097/01.med.0000436183.34931.a5.
Fabbre VD. Gender transitions in later life: a queer perspective on successful aging. Gerontologist. 2015;55(1):144–53. https://doi.org/10.1093/geront/gnu079. Epub 2014 Aug 26
Feldman J. Medical and surgical management of the transgender patient: What the primary care clinician needs to know. In: World Professional Association for Transgender Health (WPATH), editor. Standards of care for the health of transsexual, transgender, and gender nonconforming people. 7th ed; 2009. p. 365–91.
Feldman J. Medical and surgical management of the transgender patient: what the primary care clinician needs to know. The Fenway Guide to Lesbian, Gay, Bisexual, and Transgender Health. 2nd ed. Philadelphia: American College of Physicians; 2015.
Feldman J, Safer J. Hormone therapy in adults: suggested revisions to the sixth version of the standards of care. Int J Transgend. 2009;11(3):146–82. https://doi.org/10.1080/15532730903383757.
Flores AR, Herman JL, Gates GJ, Brown TNT. How many adults identify as transgender in the United States? The Williams Institute. 2016. Published Web Location. http://williamsinstitute.law.ucla.edu/wp-content/uploads/How-Many-Adults-Identify-as-Transgenderin-the-United-States.pdf.
Gamarel KE, Mereish EH, Manning D, Iwamoto M, Operario D, Nemoto T. Minority stress, smoking patterns, and cessation attempts: findings from a community-sample of transgender women in the San Francisco Bay Area. Nicotine Tob Res. 2016;18(3):306–13. https://doi.org/10.1093/ntr/ntv066
Giltay EJ, Gooren LJ, Wierckx K. Cardiovascular disease in transsexual persons treated with cross-sex hormones: reversal of the traditional sex difference in cardiovascular disease pattern. Eur J Endocinol. 2014;170(6):809–19. https://doi.org/10.1530/EJE-14-0011. Epub 2014 Mar 10
Golds G, Houdek D, Arnason T. Male hypogonadism and osteoporosis: the effects, clinical consequences, and treatment of testosterone deficiency in bone health. Int J Endocrinol. 2017; https://doi.org/10.1155/2017/4602129. Epub 2017 Mar 16
Goodman MP. Are all estrogens created equal? A review of oral vs. transdermal therapy. J Womens Health (Larchmt). 2012;21(2):161–9. https://doi.org/10.1089/jwh.2011.2839.
Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, et al. Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2017;102(11):3869–903. https://doi.org/10.1210/jc.2017-01658.
Hermosura AT, Kabigting FD. Dermatologic care of the transgender patient. Dermatol Online J. 2016;22:10.
James SE, Herman JL, Rankin S, Keisling M, Mottet L, Anafi M. The report of the 2015 U.S. transgender survey. Washington, DC: National Center for Transgender Equality; 2016.
Jin K. Modern biological theories of aging. Aging and Disease. 2010;1(2):72–4.
Joint R, Chen ZE, Cameron S. Breast and reproductive cancers in the transgender population: a systematic review. BJOG (An International Journal of Obstetrics & Gynaecology). 2018; https://doi.org/10.1111/1471-0528.15258.
Jones BA, Brewin N, Richards C, Van Eijk M, Stephenson-Allen A, Arcelus J. Investigating the outcome of the initial assessment at a national transgender health service: Time to review the process? Int J Transgenderism. 2017;18(4):427–32.
Knochel KA. Are they prepared? A look at midlife transgender people and their anticipated adaptation to aging. Minneapolis: University of Minnesota; 2011.
Maraka S, Singh Ospina N, Rodriguez-Gutierrez R, Davidge-Pitts CJ, Nippoldt TB, Prokop LJ, Murad MH. Sex steroids and cardiovascular outcomes in transgender individuals: a systematic review and meta-analysis. J Clin Endocrinol Metabol. 2017;102(11):3914–23.
New York State Department of Health AIDS Institute (NYSDOH). Older adults and sexual health: a guide for aging services providers. 2017. https://aging.ny.gov/nysofa/Older%20Adults%20Sexual%20Health%20Guide%202017%20WEB%20version.pdf.
Proctor K, Haffer SC, Ewald E, Hodge C, James CV. Identifying the transgender population in the Medicare program. Transgender Health. 2016;1(1):250–65. https://doi.org/10.1089/trgh.2016.0031.
Rhoden EL, Morgentaler A. Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasia. J Urol. 2003;170(6):2348–51.
Richards C, Bouman WP, Seal L, Barker MJ, Nieder TO, T’Sjoen G. Non-binary or genderqueer genders. Int Rev Psychiatry. 2016;28(1):95–102.
Russell S, More F. Addressing health disparities via coordination of care and interprofessional education: lesbian, gay, bisexual, and transgender health and oral health care. Dental Clinics. 2016;60(4):891–906.
Sabra JJ, Fang CX, Kundu RV. A knowledge-based assessment of dermatological care for transgender women. Transgender Health. 2018;3(1):71–3.
Safer JD, Weinand JD. Hormone therapy in transgender adults is safe with provider supervision; a review of hormone therapy sequelae for transgender individuals. J Clin Transl Endocrinol. 2015;2(2):55–60.
Schick V, Herbenick D, Reece M, Sanders SA, Dodge B, Middlestadt SE, Fortenberry JD. Sexual behaviors, condom use, and sexual health of Americans over 50: implications for sexual health promotion for older adults. J Sex Med. 2010;7(s5):315–29.
Schulz SL. The informed consent model of transgender care: an alternative to the diagnosis of gender dysphoria. First published Dec 13, 2017. Research Article. https://doi.org/10.1177/0022167817745217.
Wierckx K, Mueller S, Weyers S, Van Caenegem E, Roef G, Heylens G, et al. Long-term evaluation of cross-sex hormone treatment in transsexual persons. J Sex Med. 2012 Oct 1;9(10):2641–51.
Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321–33.
Wylie K, Knudson G, Khan SI, Bonierbale M, Watanyusakul S, Baral S. Serving transgender people: clinical care considerations and service delivery models in transgender health. Lancet. 2016;388(10042):401–11.
Zevin B, Deutsch MB. Center of Excellence for Transgender Health, Department of Family and Community Medicine, University of California San Francisco. In: Deutsch MB, editors. Guidelines for the primary and gender-affirming care of transgender and gender nonbinary people. 2nd ed. 2016. Available at www.transhealth.ucsf.edu/guidelines.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Appendix A: Medication Prescribing and Dosage Resources
Appendix A: Medication Prescribing and Dosage Resources
-
World Professional Association for Transgender Health (WPATH) Standards of Care (SOC) found at https://www.wpath.org/publications/soc
-
University of California San Francisco (UCSF) Center of Excellence (CoE) for Transgender Health Guidelines found at http://transhealth.ucsf.edu/trans?page=guidelines-home
-
Endocrine Society Clinical Practice Guidelines found at https://www.endocrine.org/guidelines-and-clinical-practice/clinical-practice-guidelines
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Houlberg, M. (2019). Endocrinology, Hormone Replacement Therapy (HRT), and Aging. In: Hardacker, C., Ducheny, K., Houlberg, M. (eds) Transgender and Gender Nonconforming Health and Aging. Springer, Cham. https://doi.org/10.1007/978-3-319-95031-0_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-95031-0_2
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-95030-3
Online ISBN: 978-3-319-95031-0
eBook Packages: MedicineMedicine (R0)